Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
Authors:
Open Access
- 14 July 2014
- journal article
- Published by Brieflands in Hepatitis Monthly
- Vol. 14 (7) , e19370
Abstract
Background: The pathogenesis of HBV-related acute-on-chronic liver failure (HBV-ACLF) is mainly based on a heightened immune-inflammatory reaction; however, the intimate underlying mechanism remains unclear. Objectives: The aim of the study was to explore potential key immune molecular targets that could serve as early predictive markers for HBV-ACLF. Patients and Methods: Twenty-seven patients with acute exacerbation of chronic hepatitis B (CHB) (defined by: alanine transaminase ≥ 20 ULN, total bilirubin ≥ 5 ULN, 40% < prothrombin time activity ≤ 60%) and without cirrhosis were divided into 18 cases which did not progress to HBV-ACLF (defined by: prothrombin time activity < 40% and development within four weeks of hepatic encephalopathy and/or ascites) and nine cases that developed HBV-ACLF. Nine healthy people defined the normal control group (NC). Interleukin-1β (IL-1β), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, TNF-α and IFN-γ protein levels were assayed by Cytometric Bead Array (CBA) in blood plasma. The ELISA method was applied to confirm IL-10 detection using the CBA method. Results: IL-4, IL-12p70 and IFN-γ were undetectable; IL-1β, IL-6, IL-8, IL-10 and TNF-α levels were significantly higher than in NC. Moreover, cytokines reached the highest levels in acute exacerbation of CHB, with the exception of IL-2 and IL-8. When comparing the HBV-ACLF patients prior to and at the time of ACLF diagnosis, IL-10 was the only cytokine that exhibited a significant decrease (P = 0.008). IL-10 concentrations were positively correlated to ALT levels (r = 0.711, P < 0.001). Conclusions: The assessment of plasma IL-10 levels in chronic hepatitis B acute exacerbation may provide an early predictive marker for progression to HBV-ACLF. Keywords: Chronic Hepatitis B; Severe Exacerbation; Chronic Liver Failure; Cytokines; Interleukin-10Keywords
This publication has 25 references indexed in Scilit:
- Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patientsJournal of Microbiology, Immunology and Infection, 2015
- Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regressionExperimental and Therapeutic Medicine, 2013
- No Correlation Between Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B Virus Infection OutcomeHepatitis Monthly, 2013
- Interleukin‐21 is upregulated in hepatitis B‐related acute‐on‐chronic liver failure and associated with severity of liver diseaseJournal of Viral Hepatitis, 2011
- Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomesHepatology, 2011
- Nucleoside Analogue Can Improve the Long-Term Prognosis of Patients with Hepatitis B Virus Infection-Associated Acute on Chronic Liver FailureDigestive Diseases and Sciences, 2010
- Prediction of the prognosis of patients with acute‐on‐chronic hepatitis B liver failure using the model for end‐stage liver disease scoring system and a novel logistic regression modelJournal of Viral Hepatitis, 2009
- Imbalanced Intrahepatic Cytokine Expression of Interferon-γ, Tumor Necrosis Factor-α, and Interleukin-10 in Patients With Acute-on-Chronic Liver Failure Associated With Hepatitis B Virus InfectionJournal of Clinical Gastroenterology, 2009
- A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis BWorld Journal of Gastroenterology, 2009
- Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis BJournal of Gastroenterology, 2008